BNET Industries
Last Fiscal Year Sales:$250.5K
- Private
- US
Dow Jones Description
High quality sampling supplies, most competitive prices, exceptional service. We are striving to become the most reliable source for the environmental and geotechnical industries.
Owner
Larry ZhangNumber of Employees 7
Contact Information
14146 Firestone Blvd
Santa Fe Springs, California 90670
1 562 802 7010
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
News & Analysis
Filter by
cel-sci corp. and m. e. garza - All News and Analysis
Why Has Cel-Sci Quietly Amended Some Previously Filed Paperwork?
Seeking Alpha
- 2009-11-12
Is the management at CEL-SCI Corporation CVM signaling that something big is coming? In mid September, on the same day that CEL-SCI Corporation announced that the U.S. Food and Drug Administration (FDA) had indicated that the company could proceed with its first clinical trial to evaluate the effect of its...
Cel-Sci's Positive Momentum Keeps Building
Seeking Alpha
- 2009-09-17
For years, it seems, CEL-SCI's CVM investors have been waiting for this perfect storm of positive developments. The company was so badly beaten and on the ropes recently, that most of the management team continued to work, for extended periods of time, without compensation. "When I came home...
Cloak and Dagger Developments at Cel-Sci Against Swine Flu
Seeking Alpha
- 2009-09-17
“The Obama administration is very worried that this could turn into a double dip double bottom recession,” said one person familiar with this situation. “They are doing everything they can to ensure that the H1N1 pandemic is not the catalyst for just such an event.” As I...
Cel-Sci Thrives With New Manufacturing Facility
Seeking Alpha
- 2009-08-25
New details have begun to emerge about Cel-Sci Corporation's CVM new, state-of-the-art "Cold-Fill" manufacturing facility which will not only be used to manufacture Multikine® the world's first immunotherapeutic agent (which is being developed as a first-line standard of care treatment for cancer) for both the Phase III trials and commercial...
CEL-SCI CEO's Bullish Biotech Play
Seeking Alpha
- 2009-08-23
CEL-SCI's CVM CEO is suddenly feeling more confident than ever. Who can blame him? There are verified reports that the company's biotechnology activates the immune system and targets the H1N1 flu's hemagglutinin molecule. The treatment apparently induces a defined immune response which could help infected swine...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Larry Zhang | Owner |
| Organization | Position | Status |
|---|---|---|
| Cel Scientific Corporation | Owner | Current |
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
